The interaction between PD-L1 and programmed death receptor 1 (PD-1) on T cells inhibits their activation and proliferation, thereby reducing their ability to eliminate tumor cells and facilitating immune evasion by the tumor. This evidence concerns the gene CD274 and neoplasm.